What's Happening?
The Department of Nutrition and Integrative Physiology at the University of Utah, in partnership with the Huntsman Cancer Institute, is actively engaged in research aimed at colorectal cancer prevention. Dr. Mary Playdon's lab is leading two NIH-funded
projects from the National Cancer Institute. The first project focuses on translating a validated blood-based dietary biomarker into clinical practice for colorectal cancer prevention. The second project investigates biomarkers related to meal timing behaviors and their connection to cancer risk. This research involves epidemiologic and translational analyses, integrating nutritional metabolomics, multiplex inflammatory protein profiling, dietary intake data, and electronic medical records. The work also includes collaboration with investigators at the American Cancer Society and the National Cancer Institute, utilizing metabolomic data from multiple cohort studies. The Huntsman Cancer Institute, an NCI-designated Comprehensive Cancer Center, provides a collaborative environment for this research, emphasizing academic achievement, patient care, and service.
Why It's Important?
This research is crucial for advancing personalized medicine in cancer prevention, particularly for colorectal cancer. By translating blood-based dietary biomarkers into clinical practice, the University of Utah and Huntsman Cancer Institute aim to provide more precise and effective prevention strategies. Understanding the role of meal timing behaviors and their associated biomarkers in cancer risk could lead to novel dietary interventions and lifestyle recommendations. This approach moves beyond general guidelines to offer individualized prevention plans based on a person's unique biological profile. The integration of various data types, including nutritional metabolomics and inflammatory protein profiling, represents a comprehensive effort to uncover complex relationships between diet, lifestyle, and cancer risk. Ultimately, this work has the potential to significantly reduce the incidence and mortality of colorectal cancer by enabling earlier and more targeted preventive measures.
What's Next?
The ongoing research in Dr. Mary Playdon's lab will continue to lead epidemiologic and translational analyses. The focus will be on integrating diverse data sets, including nutritional metabolomics, inflammatory protein profiling, dietary intake, and electronic medical records, to further understand and validate biomarkers for colorectal cancer prevention and meal timing behaviors related to cancer risk. The collaboration with the American Cancer Society and the National Cancer Institute suggests a broader effort to disseminate findings and potentially influence national cancer prevention guidelines. The ultimate goal is to translate these research findings into practical clinical applications, which would involve developing and implementing new diagnostic tools or preventive interventions based on the identified biomarkers. Future steps will likely include further validation studies and potentially clinical trials to assess the effectiveness of these biomarker-based strategies in real-world settings.
Beyond the Headlines
The work at the University of Utah and Huntsman Cancer Institute highlights a broader shift in cancer prevention towards a more personalized and data-driven approach. By focusing on biomarkers, the research moves beyond traditional risk factors to identify subtle biological indicators that can predict cancer development or progression. This has significant ethical implications, as it raises questions about how individuals will be informed of their personalized risk and the potential psychological impact of such knowledge. Legally, the integration of electronic medical records and genetic data necessitates robust privacy and data security protocols. Culturally, the emphasis on dietary biomarkers and meal timing could lead to a greater public awareness of the profound impact of lifestyle choices on cancer risk, potentially fostering a more proactive approach to health and wellness within communities. This research also underscores the increasing importance of interdisciplinary collaboration, combining nutrition science, epidemiology, and oncology to tackle complex health challenges.
